Assessing the patient reported outcomes (PROs) of enfortumab vedotin plus pembrolizumab versus platinum-based chemotherapy in patients with advanced urothelial carcinoma in the EV-302 study

Translational Andrology and Urology 2026 Open access

Read full text
Authors: Tobechukwu Okobi, Neil Vaishampayan, Deepthi Subramanya, Scott T. Tagawa
DOI: 10.21037/tau-2025-719
Cited by: 0

Fields of Study & Subjects

Bladder and Urothelial Cancer Treatments Cancer survivorship and care Urinary Bladder and Prostate Research

Publication details

Journal / source
Translational Andrology and Urology
Volume
15
Issue
1
Pages
1–1
Publication date
1 January 2026
Language
EN